Tax Aspects of Principles-Based Reserves von Jenner, Gregory F, Canter, Mark A

Volltext

T.D. 9091 von Wenzel, Robert E, Jenner, Gregory F

Volltext

T.D. 9089 von Wenzel, Robert E, Jenner, Gregory F

Volltext

T.D. 9090 von Tomaso, Judith B, Jenner, Gregory F

Volltext

T.D. 9074 von Mader, David A, Jenner, Gregory F

Volltext

T.D. 9068 von Wenzel, Robert E, Jenner, Gregory F

Volltext

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients von Shah, V, Sherborne, A L, Walker, B A, Johnson, D C, Boyle, E M, Ellis, S, Begum, D B, Proszek, P Z, Jones, J R, Pawlyn, C, Savola, S, Jenner, M W, Drayson, M T, Owen, R G, Houlston, R S, Cairns, D A, Gregory, W M, Cook, G, Davies, F E, Jackson, G H, Morgan, G J, Kaiser, M F

Volltext

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial von Jackson, Graham H, Davies, Faith E, Pawlyn, Charlotte, Cairns, David A, Striha, Alina, Collett, Corinne, Hockaday, Anna, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi, Kamaraj, Lindsay, Jindriska, Jenner, Matthew W, Cook, Gordon, Russell, Nigel H, Kaiser, Martin F, Drayson, Mark T, Owen, Roger G, Gregory, Walter M, Morgan, Gareth J

Volltext

Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk von de Tute, Ruth M, Pawlyn, Charlotte, Cairns, David A, Davies, Faith E, Menzies, Tom, Rawstron, Andy, Jones, John R, Hockaday, Anna, Henderson, Rowena, Cook, Gordon, Drayson, Mark T, Jenner, Matthew W, Kaiser, Martin F, Gregory, Walter M, Morgan, Gareth J, Jackson, Graham H, Owen, Roger G

Volltext

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial von Jones, J R, Cairns, D A, Gregory, W M, Collett, C, Pawlyn, C, Sigsworth, R, Striha, A, Henderson, R, Kaiser, M F, Jenner, M, Cook, G, Russell, N H, Williams, C, Pratt, G, Kishore, B, Lindsay, J, Drayson, M T, Davies, F E, Boyd, K D, Owen, R G, Jackson, G H, Morgan, G J

Volltext

Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim... von Jackson, Graham H, Pawlyn, Charlotte, Cairns, David A, de Tute, Ruth M, Hockaday, Anna, Collett, Corinne, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi, Kamaraj, Lindsay, Jindriska, Rocci, Alberto, Snowden, John A, Jenner, Matthew W, Cook, Gordon, Russell, Nigel H, Drayson, Mark T, Gregory, Walter M, Kaiser, Martin F, Owen, Roger G, Davies, Faith E, Morgan, Gareth J

Volltext

Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials von Bradbury, Charlotte A., Craig, Zoe, Cook, Gordon, Pawlyn, Charlotte, Cairns, David A., Hockaday, Anna, Paterson, Andrea, Jenner, Matthew W., Jones, John R., Drayson, Mark T., Owen, Roger G., Kaiser, Martin F., Gregory, Walter M., Davies, Faith E., Child, J. Anthony, Morgan, Gareth J., Jackson, Graham H.

Volltext

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients von Shah, Vallari, Sherborne, Amy L., Johnson, David C., Ellis, Sidra, Price, Amy, Chowdhury, Farzana, Kendall, Jack, Jenner, Matthew W., Drayson, Mark T., Owen, Roger G., Gregory, Walter M., Morgan, Gareth J., Davies, Faith E., Cook, Gordon, Cairns, David A., Houlston, Richard S., Jackson, Graham, Kaiser, Martin F.

Volltext

Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial von Jackson, Graham H, Davies, Faith E, Pawlyn, Charlotte, Cairns, David A, Striha, Alina, Collett, Corinne, Waterhouse, Anna, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi, Kamaraj, Lindsay, Jindriska, Allotey, David, Shafeek, Salim, Jenner, Matthew W, Cook, Gordon, Russell, Nigel H, Kaiser, Martin F, Drayson, Mark T, Owen, Roger G, Gregory, Walter M, Morgan, Gareth J, Clinical Studies Group, Uk Ncri Haematological Oncology

Volltext

Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial von Pawlyn, Charlotte, Cairns, David, Menzies, Tom, Jones, John, Jenner, Matthew, Cook, Gordon, Boyd, Kevin, Drayson, Mark, Kaiser, Martin, Owen, Roger, Gregory, Walter, Morgan, Gareth, Jackson, Graham, Davies, Faith

Volltext

Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial von Croft, James, Ellis, Sidra, Sherborne, Amy L., Sharp, Kim, Price, Amy, Jenner, Matthew W., Drayson, Mark T., Owen, Roger G., Chown, Sally, Lindsay, Jindriska, Karunanithi, Kamaraj, Hunter, Hannah, Gregory, Walter M., Davies, Faith E., Morgan, Gareth J., Cook, Gordon, Atanesyan, Lilit, Savola, Suvi, Cairns, David A., Jackson, Graham, Houlston, Richard S., Kaiser, Martin F.

Volltext

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from ‘Myeloma XI’, a multicentre, open‐label, randomi... von Jenner, Matthew W., Pawlyn, Charlotte, Davies, Faith E., Menzies, Tom, Hockaday, Anna, Olivier, Catherine, Jones, John R., Karunanithi, Kamaraj, Lindsay, Jindriska, Kishore, Bhuvan, Cook, Gordon, Drayson, Mark T., Kaiser, Martin F., Owen, Roger G., Gregory, Walter, Cairns, David A., Morgan, Gareth J., Jackson, Graham H.

Volltext

Subclonal TP53 copy number is associated with prognosis in multiple myeloma von Shah, Vallari, Johnson, David C., Sherborne, Amy L., Ellis, Sidra, Aldridge, Frances M., Howard-Reeves, Julie, Begum, Farzana, Price, Amy, Kendall, Jack, Chiecchio, Laura, Savola, Suvi, Jenner, Matthew W., Drayson, Mark T., Owen, Roger G., Gregory, Walter M., Morgan, Gareth J., Davies, Faith E., Houlston, Richard S., Cook, Gordon, Cairns, David A., Jackson, Graham, Kaiser, Martin F.

Volltext

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a... von Jackson, Graham H., Pawlyn, Charlotte, Cairns, David A., Striha, Alina, Collett, Corinne, Waterhouse, Anna, Jones, John R., Wilson, Jamie, Taylor, Craig, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D., Karunanithi, Kamaraj, Lindsay, Jindriska, Jenner, Matthew W., Cook, Gordon, Russell, Nigel H., Drayson, Mark T., Kaiser, Martin F., Owen, Roger G., Gregory, Walter M., Davies, Faith E., Morgan, Gareth J.

Volltext

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a mu... von Jackson, Graham H, Davies, Faith E, Pawlyn, Charlotte, Cairns, David A, Striha, Alina, Collett, Corinne, Waterhouse, Anna, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi, Kamaraj, Lindsay, Jindriska, Wilson, Jamie N, Jenner, Matthew W, Cook, Gordon, Kaiser, Martin F, Drayson, Mark T, Owen, Roger G, Russell, Nigel H, Gregory, Walter M, Morgan, Gareth J

Volltext